Synnovation Therapeutics Funding: $102M Raised, Series A
Synnovation Therapeutics is based in Wilmington, DE. It has raised $102M in total funding. Latest round: Series A.
Synnovation Therapeutics funding overview
Synnovation Therapeutics is based in Wilmington, DE. Synnovation Therapeutics has raised $102M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in December 2023. The round record for Synnovation Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Third Rock Ventures, Nextech Invest, Lilly Asia Ventures, Sirona Capital, Cormorant Asset Management. 5 distinct backers are named across the disclosed rounds.
Synnovation Therapeutics at a glance
Total raised
$102M
Latest round
Series A
Latest round date
December 2023
Headquarters
Wilmington, DE
Notable investors
Third Rock Ventures, Nextech Invest, Lilly Asia Ventures, Sirona Capital, Cormorant Asset Management
Frequently asked about Synnovation Therapeutics funding
How much has Synnovation Therapeutics raised?
Synnovation Therapeutics has raised $102M in total disclosed funding across the rounds on record.
Who has invested in Synnovation Therapeutics?
Third Rock Ventures, Nextech Invest, Lilly Asia Ventures, Sirona Capital, Cormorant Asset Management are named among the investors backing Synnovation Therapeutics.
What was the latest Synnovation Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2023.
Where is Synnovation Therapeutics based?
Synnovation Therapeutics is based in Wilmington, DE.
When did Synnovation Therapeutics last raise?
The last disclosed Synnovation Therapeutics round closed in December 2023 at Series A.
Totals shown for Synnovation Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Wilmington and the investors behind them below.
Companies related to Synnovation Therapeutics (36)
